Healthcare -
Biotechnology - NYSE - CH
$ 1.725
0.291 %
$ 167 M
Market Cap
-0.72
P/E
ADCT - OPERATING EXPENSES
Operating Expenses ADCT - ADC Therapeutics SA
233 M
LAST VALUE
-11.01%
2 YEAR CAGR
12.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR